RUNX1 and chronic myelomonocytic leukemia: We have identified two important features of the molecular biology of CMML: i) – RAS pathway mutations are involved, at least, in roughly half of MP-CMML; ii) – RUNX1 alterations are frequent in CMML; they may result from mutations or chromosome rearrangements.